Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin
- 8 December 2009
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 38 (5), 465-471
- https://doi.org/10.1016/j.ejps.2009.09.008
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosisBritish Journal of Pharmacology, 2009
- Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short‐term and long‐term diabetes induced by streptozotocinJournal of Pharmaceutical Sciences, 2008
- Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in ratsJournal of Pharmacy and Pharmacology, 2006
- Diabetes and Osteoporotic FracturesThe Diabetes Educator, 2005
- Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to ratsLife Sciences, 2002
- [3] Analysis of enzyme progress curves by nonlinear regressionMethods in enzymology, 1995
- Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutritionJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Altered Activities of Hepatic and Extrahepatic Microsomal Mixed Function Oxidase Enzymes in Diabetic and Adrenalectomized Diabetic RatsPharmacology, 1981
- Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Biopharmaceutics, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976